U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06951737) titled 'Evaluation Of The Effect Of SGLT-2 Inhibitors On Atrial Fibrillation Recurrence In Diabetic Patients' on April 20.
Brief Summary: Consecutive DCCV was performed until to achieve 120 patients in SR (60 DM patients who used SGLT-2 inhibitors and 60 DM patients who did not use SGLT-2 inhibitors). Patients defined as SGLT-2 inhibitor user group and control group. The two groups were monitored for AF recurrence on the first day, then at one, three, and six months after CV.
Study Start Date: Oct. 02, 2022
Study Type: OBSERVATIONAL
Condition:
Diabetes Mellitus
Atrial Fibrillation (AF)
Recruitment Status: COMPLETED
Sponsor: Bursa Postgr...